LAV Fund VI Opportunities, L.P.: insider trades.
LAV Fund VI Opportunities, L.P. reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- LAV Fund VI Opportunities, L.P.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | TenPercentOwner | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 513,067 | — | 11,089,311 | Form 4 |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 8,908,775 | — | 8,908,775 | Form 4 |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 307,738 | — | 307,738 | Form 4 |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 153,868 | — | 11,243,179 | Form 4 |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 307,738 | — | 307,738 | Form 4 |
| 2026-09-28 | ADARx Pharmaceuticals, Inc. | C | 1,667,469 | — | 10,576,244 | Form 4 |
Questions
What stock did LAV Fund VI Opportunities, L.P. buy or sell?
LAV Fund VI Opportunities, L.P. reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is LAV Fund VI Opportunities, L.P. the same person as other filers with this name?
This page covers SEC CIK 1836169 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lav-fund-vi-opportunities-l-p-1836169.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.